PHP
BCYC

Parkman Healthcare Partners’s Bicycle Therapeutics BCYC Stock Holding History

Parkman Healthcare Partners’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-352,481
Closed -$4.93M – 94
2024
Q4 		$4.93M Sell
352,481
-92,915
-21% -$1.99M 0.66% 44
2024
Q3 		$10.1M Sell
445,396
-89,667
-17% -$2.07M 1.29% 26
2024
Q2 		$10.8M Buy
535,063
+10,810
+2% +$244K 1.45% 25
2024
Q1 		$13.1M Buy
524,253
+211,364
+68% +$4.49M 1.6% 19
2023
Q4 		$5.66M Buy
312,889
+190,168
+155% +$3.15M 0.8% 39
2023
Q3 		$2.47M Sell
122,721
-49,564
-29% -$1.13M 0.45% 62
2023
Q2 		$4.4M Buy
172,285
+24,486
+17% +$569K 0.76% 38
2023
Q1 		$3.14M Buy
147,799
+56,467
+62% +$1.42M 0.68% 47
2022
Q4 		$2.7M Buy
91,332
+9,968
+12% +$267K 0.72% 51
2022
Q3 		$1.89M Buy
81,364
+20,938
+35% +$498K 0.54% 59
2022
Q2 		$1.01M Buy
60,426
+3,131
+5% +$66K 0.37% 57
2022
Q1 		$2.51M Sell
57,295
-7,505
-12% -$350K 0.74% 44
2021
Q4 		$3.94M Sell
64,800
-4,749
-7% -$262K 0.87% 36
2021
Q3 		$2.89M Sell
69,549
-11,290
-14% -$395K 0.73% 41
2021
Q2 		$2.45M Buy
80,839
+5,385
+7% +$163K 0.54% 52
2021
Q1 		$2.25M Buy
+75,454
New +$1.95M 0.52% 52

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Parkman Healthcare Partners's BCYC Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of Bicycle Therapeutics (BCYC) in Q1 2025, closing a stake of 352,481 shares — an estimated $4.93M sold.

Parkman Healthcare Partners first reported a position in BCYC in Q1 2021 and held it in 16 quarters. The position peaked at $13.1M in Q1 2024. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining Bicycle Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 352,481 Bicycle Therapeutics shares in Q1 2025, an estimated $4.93M.
  • Parkman Healthcare Partners first reported a position in Bicycle Therapeutics in Q1 2021 and held it in 16 quarters.
  • Parkman Healthcare Partners's Bicycle Therapeutics position peaked at $13.1M in Q1 2024.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.